Global Anti-dementia Drugs Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Anti-dementia Drugs Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Anti-dementia Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Donepezil
  • 1.2.3 Galantamine
  • 1.2.4 Rivastigmine
  • 1.2.5 Memantine
  • 1.2.6 Other
• 1.3 Market by Application
  • 1.3.1 Global Anti-dementia Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Pharmacy
  • 1.3.5 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Anti-dementia Drugs Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Anti-dementia Drugs Revenue by Region
  • 2.2.1 Global Anti-dementia Drugs Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Anti-dementia Drugs Revenue by Region (2019-2024)
  • 2.2.3 Global Anti-dementia Drugs Revenue by Region (2025-2030)
  • 2.2.4 Global Anti-dementia Drugs Revenue Market Share by Region (2019-2030)
• 2.3 Global Anti-dementia Drugs Sales Estimates and Forecasts 2019-2030
• 2.4 Global Anti-dementia Drugs Sales by Region
  • 2.4.1 Global Anti-dementia Drugs Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Anti-dementia Drugs Sales by Region (2019-2024)
  • 2.4.3 Global Anti-dementia Drugs Sales by Region (2025-2030)
  • 2.4.4 Global Anti-dementia Drugs Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Anti-dementia Drugs Sales by Manufacturers
  • 3.1.1 Global Anti-dementia Drugs Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Anti-dementia Drugs Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-dementia Drugs in 2023
• 3.2 Global Anti-dementia Drugs Revenue by Manufacturers
  • 3.2.1 Global Anti-dementia Drugs Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Anti-dementia Drugs Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Anti-dementia Drugs Revenue in 2023
• 3.3 Global Key Players of Anti-dementia Drugs, Industry Ranking, 2021 VS 2022
• 3.4 Global Anti-dementia Drugs Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Anti-dementia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Anti-dementia Drugs, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Anti-dementia Drugs, Product Offered and Application
• 3.8 Global Key Manufacturers of Anti-dementia Drugs, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Anti-dementia Drugs Sales by Type
  • 4.1.1 Global Anti-dementia Drugs Historical Sales by Type (2019-2024)
  • 4.1.2 Global Anti-dementia Drugs Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Anti-dementia Drugs Sales Market Share by Type (2019-2030)
• 4.2 Global Anti-dementia Drugs Revenue by Type
  • 4.2.1 Global Anti-dementia Drugs Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Anti-dementia Drugs Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Anti-dementia Drugs Revenue Market Share by Type (2019-2030)
• 4.3 Global Anti-dementia Drugs Price by Type
  • 4.3.1 Global Anti-dementia Drugs Price by Type (2019-2024)
  • 4.3.2 Global Anti-dementia Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Anti-dementia Drugs Sales by Application
  • 5.1.1 Global Anti-dementia Drugs Historical Sales by Application (2019-2024)
  • 5.1.2 Global Anti-dementia Drugs Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Anti-dementia Drugs Sales Market Share by Application (2019-2030)
• 5.2 Global Anti-dementia Drugs Revenue by Application
  • 5.2.1 Global Anti-dementia Drugs Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Anti-dementia Drugs Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Anti-dementia Drugs Revenue Market Share by Application (2019-2030)
• 5.3 Global Anti-dementia Drugs Price by Application
  • 5.3.1 Global Anti-dementia Drugs Price by Application (2019-2024)
  • 5.3.2 Global Anti-dementia Drugs Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Anti-dementia Drugs Market Size by Type
  • 6.1.1 US & Canada Anti-dementia Drugs Sales by Type (2019-2030)
  • 6.1.2 US & Canada Anti-dementia Drugs Revenue by Type (2019-2030)
• 6.2 US & Canada Anti-dementia Drugs Market Size by Application
  • 6.2.1 US & Canada Anti-dementia Drugs Sales by Application (2019-2030)
  • 6.2.2 US & Canada Anti-dementia Drugs Revenue by Application (2019-2030)
• 6.3 US & Canada Anti-dementia Drugs Market Size by Country
  • 6.3.1 US & Canada Anti-dementia Drugs Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Anti-dementia Drugs Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Anti-dementia Drugs Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Anti-dementia Drugs Market Size by Type
  • 7.1.1 Europe Anti-dementia Drugs Sales by Type (2019-2030)
  • 7.1.2 Europe Anti-dementia Drugs Revenue by Type (2019-2030)
• 7.2 Europe Anti-dementia Drugs Market Size by Application
  • 7.2.1 Europe Anti-dementia Drugs Sales by Application (2019-2030)
  • 7.2.2 Europe Anti-dementia Drugs Revenue by Application (2019-2030)
• 7.3 Europe Anti-dementia Drugs Market Size by Country
  • 7.3.1 Europe Anti-dementia Drugs Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Anti-dementia Drugs Revenue by Country (2019-2030)
  • 7.3.3 Europe Anti-dementia Drugs Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Anti-dementia Drugs Market Size by Type
  • 8.1.1 China Anti-dementia Drugs Sales by Type (2019-2030)
  • 8.1.2 China Anti-dementia Drugs Revenue by Type (2019-2030)
• 8.2 China Anti-dementia Drugs Market Size by Application
  • 8.2.1 China Anti-dementia Drugs Sales by Application (2019-2030)
  • 8.2.2 China Anti-dementia Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Anti-dementia Drugs Market Size by Type
  • 9.1.1 Asia Anti-dementia Drugs Sales by Type (2019-2030)
  • 9.1.2 Asia Anti-dementia Drugs Revenue by Type (2019-2030)
• 9.2 Asia Anti-dementia Drugs Market Size by Application
  • 9.2.1 Asia Anti-dementia Drugs Sales by Application (2019-2030)
  • 9.2.2 Asia Anti-dementia Drugs Revenue by Application (2019-2030)
• 9.3 Asia Anti-dementia Drugs Market Size by Region
  • 9.3.1 Asia Anti-dementia Drugs Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Anti-dementia Drugs Revenue by Region (2019-2030)
  • 9.3.3 Asia Anti-dementia Drugs Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Anti-dementia Drugs Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Anti-dementia Drugs Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Anti-dementia Drugs Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Anti-dementia Drugs Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Anti-dementia Drugs Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Anti-dementia Drugs Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Anti-dementia Drugs Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Anti-dementia Drugs Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Anti-dementia Drugs Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Anti-dementia Drugs Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  • 11.1.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
  • 11.1.2 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Overview
  • 11.1.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments
• 11.2 Zhien Biotechnology Co., Ltd.
  • 11.2.1 Zhien Biotechnology Co., Ltd. Company Information
  • 11.2.2 Zhien Biotechnology Co., Ltd. Overview
  • 11.2.3 Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Zhien Biotechnology Co., Ltd. Recent Developments
• 11.3 Zhejiang Huahai Pharmaceutical Co., Ltd.
  • 11.3.1 Zhejiang Huahai Pharmaceutical Co., Ltd. Company Information
  • 11.3.2 Zhejiang Huahai Pharmaceutical Co., Ltd. Overview
  • 11.3.3 Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Zhejiang Huahai Pharmaceutical Co., Ltd. Recent Developments
• 11.4 Jinri Pharmaceutical (China) Co., Ltd.
  • 11.4.1 Jinri Pharmaceutical (China) Co., Ltd. Company Information
  • 11.4.2 Jinri Pharmaceutical (China) Co., Ltd. Overview
  • 11.4.3 Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Jinri Pharmaceutical (China) Co., Ltd. Recent Developments
• 11.5 Shandong Luoxin Pharmaceutical Group Co., Ltd.
  • 11.5.1 Shandong Luoxin Pharmaceutical Group Co., Ltd. Company Information
  • 11.5.2 Shandong Luoxin Pharmaceutical Group Co., Ltd. Overview
  • 11.5.3 Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Shandong Luoxin Pharmaceutical Group Co., Ltd. Recent Developments
• 11.6 Chengdu Tongde Pharmaceutical Co., Ltd.
  • 11.6.1 Chengdu Tongde Pharmaceutical Co., Ltd. Company Information
  • 11.6.2 Chengdu Tongde Pharmaceutical Co., Ltd. Overview
  • 11.6.3 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Chengdu Tongde Pharmaceutical Co., Ltd. Recent Developments
• 11.7 Disa Pharmaceutical Group Co., Ltd.
  • 11.7.1 Disa Pharmaceutical Group Co., Ltd. Company Information
  • 11.7.2 Disa Pharmaceutical Group Co., Ltd. Overview
  • 11.7.3 Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Disa Pharmaceutical Group Co., Ltd. Recent Developments
• 11.8 Zhejiang Hisun Pharmaceutical Co., Ltd.
  • 11.8.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
  • 11.8.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Overview
  • 11.8.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
• 11.9 Zhejiang Yixin Pharmaceutical Co., Ltd.
  • 11.9.1 Zhejiang Yixin Pharmaceutical Co., Ltd. Company Information
  • 11.9.2 Zhejiang Yixin Pharmaceutical Co., Ltd. Overview
  • 11.9.3 Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Zhejiang Yixin Pharmaceutical Co., Ltd. Recent Developments
• 11.10 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd.
  • 11.10.1 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Company Information
  • 11.10.2 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Overview
  • 11.10.3 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Recent Developments
• 11.11 Livzon Group Livzon Pharmaceutical Factory
  • 11.11.1 Livzon Group Livzon Pharmaceutical Factory Company Information
  • 11.11.2 Livzon Group Livzon Pharmaceutical Factory Overview
  • 11.11.3 Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments
• 11.12 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.
  • 11.12.1 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Company Information
  • 11.12.2 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Overview
  • 11.12.3 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.12.4 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Recent Developments
• 11.13 Yueyang Xinhuada Pharmaceutical Co., Ltd.
  • 11.13.1 Yueyang Xinhuada Pharmaceutical Co., Ltd. Company Information
  • 11.13.2 Yueyang Xinhuada Pharmaceutical Co., Ltd. Overview
  • 11.13.3 Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.13.4 Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Yueyang Xinhuada Pharmaceutical Co., Ltd. Recent Developments
• 11.14 Anhui Taienkang Pharmaceutical Co., Ltd.
  • 11.14.1 Anhui Taienkang Pharmaceutical Co., Ltd. Company Information
  • 11.14.2 Anhui Taienkang Pharmaceutical Co., Ltd. Overview
  • 11.14.3 Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.14.4 Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 Anhui Taienkang Pharmaceutical Co., Ltd. Recent Developments
• 11.15 Zhejiang Jingxin Pharmaceutical Co., Ltd.
  • 11.15.1 Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Information
  • 11.15.2 Zhejiang Jingxin Pharmaceutical Co., Ltd. Overview
  • 11.15.3 Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.15.4 Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 Zhejiang Jingxin Pharmaceutical Co., Ltd. Recent Developments
• 11.16 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd.
  • 11.16.1 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Company Information
  • 11.16.2 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Overview
  • 11.16.3 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.16.4 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.16.5 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Recent Developments
• 11.17 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  • 11.17.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
  • 11.17.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Overview
  • 11.17.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.17.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.17.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments
• 11.18 Sichuan Xinston Pharmaceutical Co., Ltd.
  • 11.18.1 Sichuan Xinston Pharmaceutical Co., Ltd. Company Information
  • 11.18.2 Sichuan Xinston Pharmaceutical Co., Ltd. Overview
  • 11.18.3 Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.18.4 Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.18.5 Sichuan Xinston Pharmaceutical Co., Ltd. Recent Developments
• 11.19 Shaoxing Jingxin Pharmaceutical Co., Ltd.
  • 11.19.1 Shaoxing Jingxin Pharmaceutical Co., Ltd. Company Information
  • 11.19.2 Shaoxing Jingxin Pharmaceutical Co., Ltd. Overview
  • 11.19.3 Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.19.4 Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.19.5 Shaoxing Jingxin Pharmaceutical Co., Ltd. Recent Developments
• 11.20 Niksan Pharmaceutical
  • 11.20.1 Niksan Pharmaceutical Company Information
  • 11.20.2 Niksan Pharmaceutical Overview
  • 11.20.3 Niksan Pharmaceutical Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.20.4 Niksan Pharmaceutical Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.20.5 Niksan Pharmaceutical Recent Developments
• 11.21 Pfizer Inc
  • 11.21.1 Pfizer Inc Company Information
  • 11.21.2 Pfizer Inc Overview
  • 11.21.3 Pfizer Inc Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.21.4 Pfizer Inc Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.21.5 Pfizer Inc Recent Developments
• 11.22 Eisai Inc.
  • 11.22.1 Eisai Inc. Company Information
  • 11.22.2 Eisai Inc. Overview
  • 11.22.3 Eisai Inc. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.22.4 Eisai Inc. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.22.5 Eisai Inc. Recent Developments
• 11.23 Reddy's Laboratories
  • 11.23.1 Reddy's Laboratories Company Information
  • 11.23.2 Reddy's Laboratories Overview
  • 11.23.3 Reddy's Laboratories Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.23.4 Reddy's Laboratories Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.23.5 Reddy's Laboratories Recent Developments
• 11.24 Forest Laboratories, Inc
  • 11.24.1 Forest Laboratories, Inc Company Information
  • 11.24.2 Forest Laboratories, Inc Overview
  • 11.24.3 Forest Laboratories, Inc Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.24.4 Forest Laboratories, Inc Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.24.5 Forest Laboratories, Inc Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Anti-dementia Drugs Industry Chain Analysis
• 12.2 Anti-dementia Drugs Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Anti-dementia Drugs Production Mode & Process
• 12.4 Anti-dementia Drugs Sales and Marketing
  • 12.4.1 Anti-dementia Drugs Sales Channels
  • 12.4.2 Anti-dementia Drugs Distributors
• 12.5 Anti-dementia Drugs Customers

13 Anti-dementia Drugs Market Dynamics

• 13.1 Anti-dementia Drugs Industry Trends
• 13.2 Anti-dementia Drugs Market Drivers
• 13.3 Anti-dementia Drugs Market Challenges
• 13.4 Anti-dementia Drugs Market Restraints

14 Key Findings in the Global Anti-dementia Drugs Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Anti-dementia Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Donepezil

Table 3. Major Manufacturers of Galantamine

Table 4. Major Manufacturers of Rivastigmine

Table 5. Major Manufacturers of Memantine

Table 6. Major Manufacturers of Other

Table 7. Global Anti-dementia Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Anti-dementia Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 9. Global Anti-dementia Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 10. Global Anti-dementia Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 11. Global Anti-dementia Drugs Revenue Market Share by Region (2019-2024)

Table 12. Global Anti-dementia Drugs Revenue Market Share by Region (2025-2030)

Table 13. Global Anti-dementia Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 14. Global Anti-dementia Drugs Sales by Region (2019-2024) & (K Units)

Table 15. Global Anti-dementia Drugs Sales by Region (2025-2030) & (K Units)

Table 16. Global Anti-dementia Drugs Sales Market Share by Region (2019-2024)

Table 17. Global Anti-dementia Drugs Sales Market Share by Region (2025-2030)

Table 18. Global Anti-dementia Drugs Sales by Manufacturers (2019-2024) & (K Units)

Table 19. Global Anti-dementia Drugs Sales Share by Manufacturers (2019-2024)

Table 20. Global Anti-dementia Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 21. Global Anti-dementia Drugs Revenue Market Share by Manufacturers (2019-2024)

Table 22. Global Key Players of Anti-dementia Drugs, Industry Ranking, 2021 VS 2022 VS 2023

Table 23. Anti-dementia Drugs Price by Manufacturers (2019-2024) & (US$/Unit)

Table 24. Global Anti-dementia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 25. Global Anti-dementia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-dementia Drugs as of 2023)

Table 26. Global Key Manufacturers of Anti-dementia Drugs, Manufacturing Base Distribution and Headquarters

Table 27. Global Key Manufacturers of Anti-dementia Drugs, Product Offered and Application

Table 28. Global Key Manufacturers of Anti-dementia Drugs, Date of Enter into This Industry

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Anti-dementia Drugs Sales by Type (2019-2024) & (K Units)

Table 31. Global Anti-dementia Drugs Sales by Type (2025-2030) & (K Units)

Table 32. Global Anti-dementia Drugs Sales Share by Type (2019-2024)

Table 33. Global Anti-dementia Drugs Sales Share by Type (2025-2030)

Table 34. Global Anti-dementia Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 35. Global Anti-dementia Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 36. Global Anti-dementia Drugs Revenue Share by Type (2019-2024)

Table 37. Global Anti-dementia Drugs Revenue Share by Type (2025-2030)

Table 38. Anti-dementia Drugs Price by Type (2019-2024) & (US$/Unit)

Table 39. Global Anti-dementia Drugs Price Forecast by Type (2025-2030) & (US$/Unit)

Table 40. Global Anti-dementia Drugs Sales by Application (2019-2024) & (K Units)

Table 41. Global Anti-dementia Drugs Sales by Application (2025-2030) & (K Units)

Table 42. Global Anti-dementia Drugs Sales Share by Application (2019-2024)

Table 43. Global Anti-dementia Drugs Sales Share by Application (2025-2030)

Table 44. Global Anti-dementia Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 45. Global Anti-dementia Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 46. Global Anti-dementia Drugs Revenue Share by Application (2019-2024)

Table 47. Global Anti-dementia Drugs Revenue Share by Application (2025-2030)

Table 48. Anti-dementia Drugs Price by Application (2019-2024) & (US$/Unit)

Table 49. Global Anti-dementia Drugs Price Forecast by Application (2025-2030) & (US$/Unit)

Table 50. US & Canada Anti-dementia Drugs Sales by Type (2019-2024) & (K Units)

Table 51. US & Canada Anti-dementia Drugs Sales by Type (2025-2030) & (K Units)

Table 52. US & Canada Anti-dementia Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 53. US & Canada Anti-dementia Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 54. US & Canada Anti-dementia Drugs Sales by Application (2019-2024) & (K Units)

Table 55. US & Canada Anti-dementia Drugs Sales by Application (2025-2030) & (K Units)

Table 56. US & Canada Anti-dementia Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 57. US & Canada Anti-dementia Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 58. US & Canada Anti-dementia Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 59. US & Canada Anti-dementia Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 60. US & Canada Anti-dementia Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 61. US & Canada Anti-dementia Drugs Sales by Country (2019-2024) & (K Units)

Table 62. US & Canada Anti-dementia Drugs Sales by Country (2025-2030) & (K Units)

Table 63. Europe Anti-dementia Drugs Sales by Type (2019-2024) & (K Units)

Table 64. Europe Anti-dementia Drugs Sales by Type (2025-2030) & (K Units)

Table 65. Europe Anti-dementia Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 66. Europe Anti-dementia Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 67. Europe Anti-dementia Drugs Sales by Application (2019-2024) & (K Units)

Table 68. Europe Anti-dementia Drugs Sales by Application (2025-2030) & (K Units)

Table 69. Europe Anti-dementia Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 70. Europe Anti-dementia Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 71. Europe Anti-dementia Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 72. Europe Anti-dementia Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 73. Europe Anti-dementia Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 74. Europe Anti-dementia Drugs Sales by Country (2019-2024) & (K Units)

Table 75. Europe Anti-dementia Drugs Sales by Country (2025-2030) & (K Units)

Table 76. China Anti-dementia Drugs Sales by Type (2019-2024) & (K Units)

Table 77. China Anti-dementia Drugs Sales by Type (2025-2030) & (K Units)

Table 78. China Anti-dementia Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 79. China Anti-dementia Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 80. China Anti-dementia Drugs Sales by Application (2019-2024) & (K Units)

Table 81. China Anti-dementia Drugs Sales by Application (2025-2030) & (K Units)

Table 82. China Anti-dementia Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 83. China Anti-dementia Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 84. Asia Anti-dementia Drugs Sales by Type (2019-2024) & (K Units)

Table 85. Asia Anti-dementia Drugs Sales by Type (2025-2030) & (K Units)

Table 86. Asia Anti-dementia Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 87. Asia Anti-dementia Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 88. Asia Anti-dementia Drugs Sales by Application (2019-2024) & (K Units)

Table 89. Asia Anti-dementia Drugs Sales by Application (2025-2030) & (K Units)

Table 90. Asia Anti-dementia Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 91. Asia Anti-dementia Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 92. Asia Anti-dementia Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 93. Asia Anti-dementia Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 94. Asia Anti-dementia Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 95. Asia Anti-dementia Drugs Sales by Region (2019-2024) & (K Units)

Table 96. Asia Anti-dementia Drugs Sales by Region (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America Anti-dementia Drugs Sales by Type (2019-2024) & (K Units)

Table 98. Middle East, Africa and Latin America Anti-dementia Drugs Sales by Type (2025-2030) & (K Units)

Table 99. Middle East, Africa and Latin America Anti-dementia Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 100. Middle East, Africa and Latin America Anti-dementia Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 101. Middle East, Africa and Latin America Anti-dementia Drugs Sales by Application (2019-2024) & (K Units)

Table 102. Middle East, Africa and Latin America Anti-dementia Drugs Sales by Application (2025-2030) & (K Units)

Table 103. Middle East, Africa and Latin America Anti-dementia Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Anti-dementia Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Anti-dementia Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 106. Middle East, Africa and Latin America Anti-dementia Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 107. Middle East, Africa and Latin America Anti-dementia Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 108. Middle East, Africa and Latin America Anti-dementia Drugs Sales by Country (2019-2024) & (K Units)

Table 109. Middle East, Africa and Latin America Anti-dementia Drugs Sales by Country (2025-2030) & (K Units)

Table 110. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information

Table 111. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Description and Major Businesses

Table 112. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments

Table 115. Zhien Biotechnology Co., Ltd. Company Information

Table 116. Zhien Biotechnology Co., Ltd. Description and Major Businesses

Table 117. Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. Zhien Biotechnology Co., Ltd. Recent Developments

Table 120. Zhejiang Huahai Pharmaceutical Co., Ltd. Company Information

Table 121. Zhejiang Huahai Pharmaceutical Co., Ltd. Description and Major Businesses

Table 122. Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Zhejiang Huahai Pharmaceutical Co., Ltd. Recent Developments

Table 125. Jinri Pharmaceutical (China) Co., Ltd. Company Information

Table 126. Jinri Pharmaceutical (China) Co., Ltd. Description and Major Businesses

Table 127. Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. Jinri Pharmaceutical (China) Co., Ltd. Recent Developments

Table 130. Shandong Luoxin Pharmaceutical Group Co., Ltd. Company Information

Table 131. Shandong Luoxin Pharmaceutical Group Co., Ltd. Description and Major Businesses

Table 132. Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. Shandong Luoxin Pharmaceutical Group Co., Ltd. Recent Developments

Table 135. Chengdu Tongde Pharmaceutical Co., Ltd. Company Information

Table 136. Chengdu Tongde Pharmaceutical Co., Ltd. Description and Major Businesses

Table 137. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. Chengdu Tongde Pharmaceutical Co., Ltd. Recent Developments

Table 140. Disa Pharmaceutical Group Co., Ltd. Company Information

Table 141. Disa Pharmaceutical Group Co., Ltd. Description and Major Businesses

Table 142. Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 144. Disa Pharmaceutical Group Co., Ltd. Recent Developments

Table 145. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information

Table 146. Zhejiang Hisun Pharmaceutical Co., Ltd. Description and Major Businesses

Table 147. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 148. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 149. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments

Table 150. Zhejiang Yixin Pharmaceutical Co., Ltd. Company Information

Table 151. Zhejiang Yixin Pharmaceutical Co., Ltd. Description and Major Businesses

Table 152. Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 153. Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 154. Zhejiang Yixin Pharmaceutical Co., Ltd. Recent Developments

Table 155. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Company Information

Table 156. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Description and Major Businesses

Table 157. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 158. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 159. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Recent Developments

Table 160. Livzon Group Livzon Pharmaceutical Factory Company Information

Table 161. Livzon Group Livzon Pharmaceutical Factory Description and Major Businesses

Table 162. Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 163. Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 164. Livzon Group Livzon Pharmaceutical Factory Recent Developments

Table 165. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Company Information

Table 166. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Description and Major Businesses

Table 167. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 168. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 169. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Recent Developments

Table 170. Yueyang Xinhuada Pharmaceutical Co., Ltd. Company Information

Table 171. Yueyang Xinhuada Pharmaceutical Co., Ltd. Description and Major Businesses

Table 172. Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 173. Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 174. Yueyang Xinhuada Pharmaceutical Co., Ltd. Recent Developments

Table 175. Anhui Taienkang Pharmaceutical Co., Ltd. Company Information

Table 176. Anhui Taienkang Pharmaceutical Co., Ltd. Description and Major Businesses

Table 177. Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 178. Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 179. Anhui Taienkang Pharmaceutical Co., Ltd. Recent Developments

Table 180. Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Information

Table 181. Zhejiang Jingxin Pharmaceutical Co., Ltd. Description and Major Businesses

Table 182. Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 183. Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 184. Zhejiang Jingxin Pharmaceutical Co., Ltd. Recent Developments

Table 185. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Company Information

Table 186. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Description and Major Businesses

Table 187. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 188. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 189. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Recent Developments

Table 190. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information

Table 191. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Description and Major Businesses

Table 192. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 193. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 194. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments

Table 195. Sichuan Xinston Pharmaceutical Co., Ltd. Company Information

Table 196. Sichuan Xinston Pharmaceutical Co., Ltd. Description and Major Businesses

Table 197. Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 198. Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 199. Sichuan Xinston Pharmaceutical Co., Ltd. Recent Developments

Table 200. Shaoxing Jingxin Pharmaceutical Co., Ltd. Company Information

Table 201. Shaoxing Jingxin Pharmaceutical Co., Ltd. Description and Major Businesses

Table 202. Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 203. Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 204. Shaoxing Jingxin Pharmaceutical Co., Ltd. Recent Developments

Table 205. Niksan Pharmaceutical Company Information

Table 206. Niksan Pharmaceutical Description and Major Businesses

Table 207. Niksan Pharmaceutical Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 208. Niksan Pharmaceutical Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 209. Niksan Pharmaceutical Recent Developments

Table 210. Pfizer Inc Company Information

Table 211. Pfizer Inc Description and Major Businesses

Table 212. Pfizer Inc Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 213. Pfizer Inc Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 214. Pfizer Inc Recent Developments

Table 215. Eisai Inc. Company Information

Table 216. Eisai Inc. Description and Major Businesses

Table 217. Eisai Inc. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 218. Eisai Inc. Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 219. Eisai Inc. Recent Developments

Table 220. Reddy's Laboratories Company Information

Table 221. Reddy's Laboratories Description and Major Businesses

Table 222. Reddy's Laboratories Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 223. Reddy's Laboratories Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 224. Reddy's Laboratories Recent Developments

Table 225. Forest Laboratories, Inc Company Information

Table 226. Forest Laboratories, Inc Description and Major Businesses

Table 227. Forest Laboratories, Inc Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 228. Forest Laboratories, Inc Anti-dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 229. Forest Laboratories, Inc Recent Developments

Table 230. Key Raw Materials Lists

Table 231. Raw Materials Key Suppliers Lists

Table 232. Anti-dementia Drugs Distributors List

Table 233. Anti-dementia Drugs Customers List

Table 234. Anti-dementia Drugs Market Trends

Table 235. Anti-dementia Drugs Market Drivers

Table 236. Anti-dementia Drugs Market Challenges

Table 237. Anti-dementia Drugs Market Restraints

Table 238. Research Programs/Design for This Report

Table 239. Key Data Information from Secondary Sources

Table 240. Key Data Information from Primary Sources

List of Figures

Figure 1. Anti-dementia Drugs Product Picture

Figure 2. Global Anti-dementia Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Anti-dementia Drugs Market Share by Type: 2023 & 2030

Figure 4. Donepezil Product Picture

Figure 5. Galantamine Product Picture

Figure 6. Rivastigmine Product Picture

Figure 7. Memantine Product Picture

Figure 8. Other Product Picture

Figure 9. Global Anti-dementia Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 10. Global Anti-dementia Drugs Market Share by Application: 2023 & 2030

Figure 11. Hospital

Figure 12. Clinic

Figure 13. Pharmacy

Figure 14. Other

Figure 15. Anti-dementia Drugs Report Years Considered

Figure 16. Global Anti-dementia Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 18. Global Anti-dementia Drugs Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 19. Global Anti-dementia Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 20. Global Anti-dementia Drugs Revenue Market Share by Region (2019-2030)

Figure 21. Global Anti-dementia Drugs Sales (2019-2030) & (K Units)

Figure 22. Global Anti-dementia Drugs Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 23. Global Anti-dementia Drugs Sales Market Share by Region (2019-2030)

Figure 24. US & Canada Anti-dementia Drugs Sales YoY (2019-2030) & (K Units)

Figure 25. US & Canada Anti-dementia Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Europe Anti-dementia Drugs Sales YoY (2019-2030) & (K Units)

Figure 27. Europe Anti-dementia Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 28. China Anti-dementia Drugs Sales YoY (2019-2030) & (K Units)

Figure 29. China Anti-dementia Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 30. Asia (excluding China) Anti-dementia Drugs Sales YoY (2019-2030) & (K Units)

Figure 31. Asia (excluding China) Anti-dementia Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 32. Middle East, Africa and Latin America Anti-dementia Drugs Sales YoY (2019-2030) & (K Units)

Figure 33. Middle East, Africa and Latin America Anti-dementia Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 34. Global Anti-dementia Drugs Sales Share by Manufacturers (2023)

Figure 35. The Anti-dementia Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 36. Global Anti-dementia Drugs Revenue Share by Manufacturers (2023)

Figure 37. The Top 5 and 10 Largest Manufacturers of Anti-dementia Drugs in the World: Market Share by Anti-dementia Drugs Revenue in 2023

Figure 38. Global Anti-dementia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 39. Global Anti-dementia Drugs Sales Market Share by Type (2019-2030)

Figure 40. Global Anti-dementia Drugs Revenue Market Share by Type (2019-2030)

Figure 41. Global Anti-dementia Drugs Sales Market Share by Application (2019-2030)

Figure 42. Global Anti-dementia Drugs Revenue Market Share by Application (2019-2030)

Figure 43. US & Canada Anti-dementia Drugs Sales Market Share by Type (2019-2030)

Figure 44. US & Canada Anti-dementia Drugs Revenue Market Share by Type (2019-2030)

Figure 45. US & Canada Anti-dementia Drugs Sales Market Share by Application (2019-2030)

Figure 46. US & Canada Anti-dementia Drugs Revenue Market Share by Application (2019-2030)

Figure 47. US & Canada Anti-dementia Drugs Revenue Share by Country (2019-2030)

Figure 48. US & Canada Anti-dementia Drugs Sales Share by Country (2019-2030)

Figure 49. US Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 50. Canada Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 51. Europe Anti-dementia Drugs Sales Market Share by Type (2019-2030)

Figure 52. Europe Anti-dementia Drugs Revenue Market Share by Type (2019-2030)

Figure 53. Europe Anti-dementia Drugs Sales Market Share by Application (2019-2030)

Figure 54. Europe Anti-dementia Drugs Revenue Market Share by Application (2019-2030)

Figure 55. Europe Anti-dementia Drugs Revenue Share by Country (2019-2030)

Figure 56. Europe Anti-dementia Drugs Sales Share by Country (2019-2030)

Figure 57. Germany Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 58. France Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 59. U.K. Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 60. Italy Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 61. Russia Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 62. China Anti-dementia Drugs Sales Market Share by Type (2019-2030)

Figure 63. China Anti-dementia Drugs Revenue Market Share by Type (2019-2030)

Figure 64. China Anti-dementia Drugs Sales Market Share by Application (2019-2030)

Figure 65. China Anti-dementia Drugs Revenue Market Share by Application (2019-2030)

Figure 66. Asia Anti-dementia Drugs Sales Market Share by Type (2019-2030)

Figure 67. Asia Anti-dementia Drugs Revenue Market Share by Type (2019-2030)

Figure 68. Asia Anti-dementia Drugs Sales Market Share by Application (2019-2030)

Figure 69. Asia Anti-dementia Drugs Revenue Market Share by Application (2019-2030)

Figure 70. Asia Anti-dementia Drugs Revenue Share by Region (2019-2030)

Figure 71. Asia Anti-dementia Drugs Sales Share by Region (2019-2030)

Figure 72. Japan Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 73. South Korea Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 74. China Taiwan Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 75. Southeast Asia Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 76. India Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 77. Australia Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 78. Middle East, Africa and Latin America Anti-dementia Drugs Sales Market Share by Type (2019-2030)

Figure 79. Middle East, Africa and Latin America Anti-dementia Drugs Revenue Market Share by Type (2019-2030)

Figure 80. Middle East, Africa and Latin America Anti-dementia Drugs Sales Market Share by Application (2019-2030)

Figure 81. Middle East, Africa and Latin America Anti-dementia Drugs Revenue Market Share by Application (2019-2030)

Figure 82. Middle East, Africa and Latin America Anti-dementia Drugs Revenue Share by Country (2019-2030)

Figure 83. Middle East, Africa and Latin America Anti-dementia Drugs Sales Share by Country (2019-2030)

Figure 84. Brazil Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 85. Mexico Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 86. Turkey Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 87. Israel Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 88. GCC Countries Anti-dementia Drugs Revenue (2019-2030) & (US$ Million)

Figure 89. Anti-dementia Drugs Value Chain

Figure 90. Anti-dementia Drugs Production Process

Figure 91. Channels of Distribution (Direct Vs Distribution)

Figure 92. Bottom-up and Top-down Approaches for This Report

Figure 93. Data Triangulation

Figure 94. Key Executives Interviewed